SLFN5 and glioblastoma: Decreasing SLFN5 leads to increased cellular susceptibility to IFN-induced antiproliferative responses in glioblastoma cells, implying that SLFN5 functions as a negative regulator of the IFN response in glioma cancer cells [65].